Research AI

Scans

Tools

Watchlists

Home

Charts

Watchlist

Products

Molbio Diagnostics Ltd

MOLBIO

NSE

₹1,434.80-8.87%19 Oct 2026

Reports

Medical Equipment

Molbio Diagnostics Ltd

MOLBIO

NSE

₹1,434.80

-8.87%

19 Oct 2026

SOICxStockScans Reports

Ask AI

Medical Equipment

Indices

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Price

Charts

Documents

Edit Ratios

Mkt Cap

Market Capitalization

₹16,535Cr

Close Price

₹1,434.80

Industry

Medical Equipment

Price To Earnings

98.88

Price To Sales

11.44

Revenue

₹1,446Cr

Rev Gr TTM

Revenue Growth TTM

—

PAT Gr TTM

PAT Growth TTM

—

Consolidated

Standalone

Numbers

Percentage

Quarter	Jun 2025	Mar 2026	Jun 2026
Revenue RevenueCr	100	561	408
Growth YoY Revenue Growth YoY%			309.6
Expenses ExpensesCr	115	402	308
Operating Profit Operating ProfitCr	-15	159	101
OPM OPM%	-15.3	28.3	24.6
Other Income Other IncomeCr	0	5	3
Interest Expense Interest ExpenseCr	4	12	11
Depreciation DepreciationCr	12	20	17
PBT PBTCr	-31	132	76
Tax TaxCr	-7	36	23
PAT PATCr	-24	96	53
Growth YoY PAT Growth YoY%			320.3
NPM NPM%	-24.0	17.1	12.9
EPS EPS₹	-2.1	8.1	5.2

Quarter	Jun 2025	Mar 2026	Jun 2026
Revenue RevenueCr	100	561	408
Growth YoY Revenue Growth YoY%			309.6
Expenses ExpensesCr	115	402	308
Operating Profit Operating ProfitCr	-15	159	101
OPM OPM%	-15.3	28.3	24.6
Other Income Other IncomeCr	0	5	3
Interest Expense Interest ExpenseCr	4	12	11
Depreciation DepreciationCr	12	20	17
PBT PBTCr	-31	132	76
Tax TaxCr	-7	36	23
PAT PATCr	-24	96	53
Growth YoY PAT Growth YoY%			320.3
NPM NPM%	-24.0	17.1	12.9
EPS EPS₹	-2.1	8.1	5.2

Consolidated

Standalone

Numbers

Percentage

Financial Year	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Revenue RevenueCr	52	1,272	776	332	837	1,020	1,446
Growth Revenue Growth%		2,367.1	-39.0	-57.2	151.6	22.0	41.7
Expenses ExpensesCr	73	586	406	289	602	758	1,124
Operating Profit Operating ProfitCr	-22	686	371	43	234	262	321
OPM OPM%	-41.8	53.9	47.8	13.0	28.0	25.7	22.2
Other Income Other IncomeCr	1	2	5	5	-49	-6	7
Interest Expense Interest ExpenseCr	22	36	26	7	14	18	33
Depreciation DepreciationCr	14	21	55	32	41	45	64
PBT PBTCr	-58	630	296	10	130	194	231
Tax TaxCr	-42	162	81	13	46	56	67
PAT PATCr	-16	468	215	-3	84	139	164
Growth PAT Growth%		2,973.3	-54.0	-101.6	2,525.0	65.9	18.4
NPM NPM%	-31.6	36.8	27.7	-1.0	10.0	13.6	11.3
EPS EPS₹	-80.5	2,313.4	974.0	-0.1	9.1	12.9	14.8

Financial Year	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Revenue RevenueCr	52	1,272	776	332	837	1,020	1,446
Growth Revenue Growth%		2,367.1	-39.0	-57.2	151.6	22.0	41.7
Expenses ExpensesCr	73	586	406	289	602	758	1,124
Operating Profit Operating ProfitCr	-22	686	371	43	234	262	321
OPM OPM%	-41.8	53.9	47.8	13.0	28.0	25.7	22.2
Other Income Other IncomeCr	1	2	5	5	-49	-6	7
Interest Expense Interest ExpenseCr	22	36	26	7	14	18	33
Depreciation DepreciationCr	14	21	55	32	41	45	64
PBT PBTCr	-58	630	296	10	130	194	231
Tax TaxCr	-42	162	81	13	46	56	67
PAT PATCr	-16	468	215	-3	84	139	164
Growth PAT Growth%		2,973.3	-54.0	-101.6	2,525.0	65.9	18.4
NPM NPM%	-31.6	36.8	27.7	-1.0	10.0	13.6	11.3
EPS EPS₹	-80.5	2,313.4	974.0	-0.1	9.1	12.9	14.8

Consolidated

Standalone

Numbers

Percentage

Financial Year	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	2	2	2	2	2	2	11
Reserves ReservesCr	-127	333	708	719	821	966	1,158
Current Liabilities Current LiabilitiesCr	206	336	212	258	343	442	557
Non Current Liabilities Non Current LiabilitiesCr	234	174	16	39	49	53	282
Total Liabilities Total LiabilitiesCr	315	845	940	1,034	1,221	1,462	2,148
Current Assets Current AssetsCr	129	556	634	611	823	930	1,385
Non Current Assets Non Current AssetsCr	186	289	305	423	398	532	764
Total Assets Total AssetsCr	315	845	940	1,034	1,221	1,462	2,148

Financial Year	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	2	2	2	2	2	2	11
Reserves ReservesCr	-127	333	708	719	821	966	1,158
Current Liabilities Current LiabilitiesCr	206	336	212	258	343	442	557
Non Current Liabilities Non Current LiabilitiesCr	234	174	16	39	49	53	282
Total Liabilities Total LiabilitiesCr	315	845	940	1,034	1,221	1,462	2,148
Current Assets Current AssetsCr	129	556	634	611	823	930	1,385
Non Current Assets Non Current AssetsCr	186	289	305	423	398	532	764
Total Assets Total AssetsCr	315	845	940	1,034	1,221	1,462	2,148

Consolidated

Standalone

Financial Year	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	-87	360	101	64	10	287	50
Investing Cash Flow Investing Cash FlowCr	-17	-145	-88	-40	-45	-123	-93
Financing Cash Flow Financing Cash FlowCr	110	-204	-22	18	-32	-26	276
Net Cash Flow Net Cash FlowCr	5	11	-9	43	-67	138	233
Free Cash Flow Free Cash FlowCr	-98	226	36	50	-7	233	1
CFO To PAT CFO To PAT%	535.0	77.0	46.8	-1,861.6	11.5	207.2	30.7
CFO To EBITDA CFO To EBITDA%	404.1	52.5	27.2	148.6	4.1	109.5	15.7

Financial Year	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	-87	360	101	64	10	287	50
Investing Cash Flow Investing Cash FlowCr	-17	-145	-88	-40	-45	-123	-93
Financing Cash Flow Financing Cash FlowCr	110	-204	-22	18	-32	-26	276
Net Cash Flow Net Cash FlowCr	5	11	-9	43	-67	138	233
Free Cash Flow Free Cash FlowCr	-98	226	36	50	-7	233	1
CFO To PAT CFO To PAT%	535.0	77.0	46.8	-1,861.6	11.5	207.2	30.7
CFO To EBITDA CFO To EBITDA%	404.1	52.5	27.2	148.6	4.1	109.5	15.7

Consolidated

Standalone

Financial Year	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr								16,535
Price To Earnings Price To Earnings								98.9
Price To Sales Price To Sales								11.4
Price To Book Price To Book								12.1
EV To EBITDA EV To EBITDA								56.7
Profitability Ratios Profitability Ratios
GPM GPM%	29.8	69.1	62.2	51.0	55.6	54.3	55.8	55.8
OPM OPM%	-41.8	53.9	47.8	13.0	28.0	25.7	22.2	22.2
NPM NPM%	-31.6	36.8	27.7	-1.0	10.0	13.6	11.3	11.3
ROCE ROCE%	-12.9	111.8	39.2	1.9	14.3	19.0	16.3	16.3
ROE ROE%	13.0	139.7	30.3	-0.5	10.2	14.3	14.0	14.0
ROA ROA%	-5.2	55.3	22.9	-0.3	6.8	9.5	7.6	7.6
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

Financial Year	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr								16,535
Price To Earnings Price To Earnings								98.9
Price To Sales Price To Sales								11.4
Price To Book Price To Book								12.1
EV To EBITDA EV To EBITDA								56.7
Profitability Ratios Profitability Ratios
GPM GPM%	29.8	69.1	62.2	51.0	55.6	54.3	55.8	55.8
OPM OPM%	-41.8	53.9	47.8	13.0	28.0	25.7	22.2	22.2
NPM NPM%	-31.6	36.8	27.7	-1.0	10.0	13.6	11.3	11.3
ROCE ROCE%	-12.9	111.8	39.2	1.9	14.3	19.0	16.3	16.3
ROE ROE%	13.0	139.7	30.3	-0.5	10.2	14.3	14.0	14.0
ROA ROA%	-5.2	55.3	22.9	-0.3	6.8	9.5	7.6	7.6
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

	MOLBIO	POLYMED	TARSONS	LAXMIDENTL	HSIL	DENTALKART	PREVEST
Market CapitalizationMkt CapCr	16,535	15,718	1,677	1,000	899	763	486
Close PriceClose₹	1,434.80	1,550.70	315.25	181.80	618.60	440.00	405.00
IndustryIndustry	Medical Equipment	Medical Equipment	Medical Equipment	Medical Equipment	Medical Equipment	Medical Equipment	Medical Equipment
Price To EarningsPE	98.88	49.88	150.84	32.12	40.19	65.19	22.38
Price To SalesPS	11.44	7.87	3.80	3.49	3.88	2.53	6.47
RevenueRevenueCr	1,446	1,997	441	287	232	302	75
Revenue Growth TTMRev Gr TTM%		18.3%	10.6%	17.1%	117.4%	17.9%	14.8%
PAT Growth TTMPAT Gr TTM%		-12.5%	-59.7%	57.4%	126.3%	-30.2%	14.9%

	MOLBIO	POLYMED	TARSONS	LAXMIDENTL	HSIL	DENTALKART	PREVEST
Market CapitalizationMkt CapCr	16,535	15,718	1,677	1,000	899	763	486
Close PriceClose₹	1,434.80	1,550.70	315.25	181.80	618.60	440.00	405.00
IndustryIndustry	Medical Equipment	Medical Equipment	Medical Equipment	Medical Equipment	Medical Equipment	Medical Equipment	Medical Equipment
Price To EarningsPE	98.88	49.88	150.84	32.12	40.19	65.19	22.38
Price To SalesPS	11.44	7.87	3.80	3.49	3.88	2.53	6.47
RevenueRevenueCr	1,446	1,997	441	287	232	302	75
Revenue Growth TTMRev Gr TTM%		18.3%	10.6%	17.1%	117.4%	17.9%	14.8%
PAT Growth TTMPAT Gr TTM%		-12.5%	-59.7%	57.4%	126.3%	-30.2%	14.9%

No recent documents found for this company.

FY2026

Jun 26

Result PPT Transcript Summary

No recent documents found for this company.

Jun 26

Result PPT Transcript Summary

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in

349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies